BEIJING, Aug. 25, 2011 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (NKBP.NSDQ)a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hospital-based medical products, today announced financial results for the second quarter of 2011.

Second Quarter 2011 Financial Highlights

       
          --  Revenue was RMB79.5 million ($12.3 million)1 compared to RMB82.4 million
              in the prior year period;
          --  Baquting revenue was RMB76.1 million ($11.8 million) compared to RMB77.8
              million in the prior year period;
          --  Gross profit was RMB70.9 million ($11.0 million) compared to RMB73.2
              million in the prior year period;
          --  Gross margin was 89.2% compared to 88.8% in the prior year period;
          --  Operating income was RMB21.0 million ($3.3 million); and
          --  Net income was RMB14.2 ($2.2 million) or RMB0.72 ($0.11) per diluted
              ADS2.